167 related articles for article (PubMed ID: 25052560)
21. Online feedback focusing algorithm for hyperthermia cancer treatment.
Cheng KS; Stakhursky V; Stauffer P; Dewhirst M; Das SK
Int J Hyperthermia; 2007 Nov; 23(7):539-54. PubMed ID: 17943551
[TBL] [Abstract][Full Text] [Related]
22. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
[TBL] [Abstract][Full Text] [Related]
23. Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study.
Cordeiro ER; Geijsen DE; Zum Vörde Sive Vörding PJ; Schooneveldt G; Sijbrands J; Hulshof MC; de la Rosette J; de Reijke TM; Crezee H
J Endourol; 2013 Dec; 27(12):1504-9. PubMed ID: 24112045
[TBL] [Abstract][Full Text] [Related]
24. The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
Bahouth Z; Halachmi S; Moskovitz B; Nativ O
Expert Rev Anticancer Ther; 2016; 16(2):189-98. PubMed ID: 26618756
[TBL] [Abstract][Full Text] [Related]
25. Using MRI to measure position and anatomy changes and assess their impact on the accuracy of hyperthermia treatment planning for cervical cancer.
VilasBoas-Ribeiro I; Franckena M; van Rhoon GC; Hernández-Tamames JA; Paulides MM
Int J Hyperthermia; 2023; 40(1):2151648. PubMed ID: 36535922
[TBL] [Abstract][Full Text] [Related]
26. Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma.
Yuan Y; Cheng KS; Craciunescu OI; Stauffer PR; Maccarini PF; Arunachalam K; Vujaskovic Z; Dewhirst MW; Das SK
Med Phys; 2012 Mar; 39(3):1170-81. PubMed ID: 22380348
[TBL] [Abstract][Full Text] [Related]
27. The hot-to-cold spot quotient for SAR-based treatment planning in deep microwave hyperthermia.
Zanoli M; Dobšíček Trefná H
Int J Hyperthermia; 2022; 39(1):1421-1439. PubMed ID: 36396127
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan.
Gellermann J; Wust P; Stalling D; Seebass M; Nadobny J; Beck R; Hege H; Deuflhard P; Felix R
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1145-56. PubMed ID: 10863088
[TBL] [Abstract][Full Text] [Related]
29. Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?
Kiss B; Schneider S; Thalmann GN; Roth B
Int J Urol; 2015 Feb; 22(2):158-62. PubMed ID: 25339291
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer.
Colombo R; Da Pozzo LF; Lev A; Freschi M; Gallus G; Rigatti P
J Urol; 1996 Apr; 155(4):1227-32. PubMed ID: 8632537
[TBL] [Abstract][Full Text] [Related]
31. Artefacts in intracavitary temperature measurements during regional hyperthermia.
Kok HP; Van den Berg CA; Van Haaren PM; Crezee J
Phys Med Biol; 2007 Sep; 52(17):5157-71. PubMed ID: 17762078
[TBL] [Abstract][Full Text] [Related]
32. Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression.
Maffezzini M; Campodonico F; Canepa G; Manuputty EE; Tamagno S; Puntoni M
Cancer Chemother Pharmacol; 2014 May; 73(5):925-30. PubMed ID: 24585046
[TBL] [Abstract][Full Text] [Related]
33. A performance analysis of echographic ultrasonic techniques for non-invasive temperature estimation in hyperthermia range using phantoms with scatterers.
Bazán I; Vazquez M; Ramos A; Vera A; Leija L
Ultrasonics; 2009 Mar; 49(3):358-76. PubMed ID: 19100591
[TBL] [Abstract][Full Text] [Related]
34. [The use of an early postoperative interstitial-hyperthermia combination therapy in malignant gliomas].
Stahl H; Wust P; Maier-Hauff K; Seebass M; Mischel M; Gremmler M; Golde G; Löffel J; Felix R
Strahlenther Onkol; 1995 Sep; 171(9):510-24. PubMed ID: 7570300
[TBL] [Abstract][Full Text] [Related]
35. Current state of the art of regional hyperthermia treatment planning: a review.
Kok HP; Wust P; Stauffer PR; Bardati F; van Rhoon GC; Crezee J
Radiat Oncol; 2015 Sep; 10():196. PubMed ID: 26383087
[TBL] [Abstract][Full Text] [Related]
36. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
Nativ O; Witjes JA; Hendricksen K; Cohen M; Kedar D; Sidi A; Colombo R; Leibovitch I
J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278
[TBL] [Abstract][Full Text] [Related]
37. Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations.
Tilly W; Wust P; Rau B; Harder C; Gellermann J; Schlag P; Budach V; Felix R
Int J Hyperthermia; 2001; 17(2):172-88. PubMed ID: 11252360
[TBL] [Abstract][Full Text] [Related]
38. Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed.
Fatehi D; van der Zee J; van der Wal E; Van Wieringen WN; Van Rhoon GC
Int J Hyperthermia; 2006 Jun; 22(4):353-63. PubMed ID: 16754355
[TBL] [Abstract][Full Text] [Related]
39. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer.
Juang T; Stauffer PR; Craciunescu OA; Maccarini PF; Yuan Y; Das SK; Dewhirst MW; Inman BA; Vujaskovic Z
Int J Hyperthermia; 2014 May; 30(3):176-83. PubMed ID: 24669804
[TBL] [Abstract][Full Text] [Related]
40. Complaint-adaptive power density optimization as a tool for HTP-guided steering in deep hyperthermia treatment of pelvic tumors.
Canters RA; Franckena M; van der Zee J; Van Rhoon GC
Phys Med Biol; 2008 Dec; 53(23):6799-820. PubMed ID: 19001699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
